Audrey’s Life Science Meeting Picks for Nov., 2009 (Nov. 3rd Edition)

*************************************************************************************

Licensing Executives Society, SF Chapter, Thursday Lunchtime, Nov. 5, 2009

Topic: “University Technology Transfer - A Comparison of U.S. and European Approaches”Panel:Teri Willey, Chief Executive of Cambridge Enterprise LimitedThe commercialisation office of the University of CambridgeKatharine Ku, Director of the Office of Technology Licensing (OTL)Stanford UniversityDate and Time: Thursday, November 5, 11:30 AM – 2:00 PM11:30 AM - 12:30 PM: Lunch & Registration12:30 PM - 1:30 PM: Presentation1:30 PM - 2:00 PM: Q&A & NetworkingLocation:: Kirkland & Ellis LLP, 555 California Street, 27th Floor, San Francisco, CA 94104Click here for more information and online registration

Online RegistrationEarly, by October 30, 9 PMLES Members: $35Non-Members: $40After October 30LES Members: $40Non-Members: $45Online Registration Deadline:  Wednesday, November 4For questions about the event:Rob WarnerLES SF Chapter Marketing Chairrob.warner@fticonsulting.com

**************************************************************************************

QED@QB3 – UCSF, Thursday Lunch, Thursday, Nov. 5, 2009

Topic: “Coming to Terms with your Term Sheet”Speakers: Tom Duley & Sarita Jain of Morgan, Lewis & Bockius LLPDate and Time: Thursday November 5, 2009, 12:00 noon – 1:00pm Location: Byers Hall Room 212, UCSF Mission Bay Campus Cost: Free

Topic DescriptionTerm Sheets are the kernel around which you build a critical licensing or partnering transaction. They are meant to capture key terms—sometimes with intentional vagueness. Join Tom Duley, Counsel Morgan, Lewis & Bockius LLP and Sarita Jain, Principal Venture Investments in this exploration of both business and legal aspects of Term Sheet negotiations.Lunch provided, but space is limited so please reserve a seat here. http://www.acteva.com/booking.cfm?bevaid=190307

1 5/6/2023

******************************************************************************************UCSF Program, Thursday Evening, Nov. 5, 2009

Topic: ““A Social Entrepreneur’s Journey in Global Health”. Speaker: Victoria Hale Date and Time: Thursday November 5, 2009!, 6:00pm-7:30 Refreshments to follow Register Now!Location: Genentech Hall, Byers Auditorium 600 16th Street, San Francisco, CA 94158Cost: $20 online and $30 walkin; $10.00 for postdocs and students Acteva Registration required http://www.acteva.com/booking.cfm?bevaid=191621

Speaker BioVictoria Hale, PhD, is the Founder of Medicines360, a pharmaceutical scientist, and a global health social entrepreneur. Her passion is the development of important new medicines for all of humanity, with the specific goal to reduce health inequities. Dr. Hale is Founder & Chair Emeritus of OneWorld Health, the first non-profit pharmaceutical company in the US. She founded the company in 2000 and served as its first Chairman and CEO (2000-2008). Under her leadership, the organization developed a new cure for visceral leishmaniasis, launched a novel approach to treat dehydrating diarrhea, and developed a platform technology to reduce the cost of malaria drugs by more than 10-fold. Currently, Dr. Hale is the CEO of Medicine360, a non-profit pharmaceutical company that addresses the unmet needs of women and children by developing innovative, affordable, and sustainable medical solutions to promote better health. The Haas School of Business and the Lester Center for Entrepreneurship and Innovation at UC Berkeley invite you to learn more about the 12th Annual UC Berkeley Business Plan Competition. Showcase your innovative business model to the UCSF and UC Berkeley communities and beyond! Winning teams receive cash awards up to $30,000. Expand your network, meet potential partners and learn about the exciting ideas at the UC Berkeley Business Plan Competition mixer immediately following Dr. Victoria Hale’s speech on Thursday November 5, 2009 from 7:30pm-8:30pm in Genentech Hall. Click here for more information.

**********************************************************************************

Triple Ring Technologies, Thursday Evening, Nov. 5, 2009

Topic: “The Early History of MRI”Speaker: Waldo Hinshaw, Principal Scientist, Triple Ring Technologies

Date and Time: Thursday, November 5, 2009, 6:00 – 9:00 pm, presentation begins at 6:45 pmLocation: Triple Ring Technologies, 39655 Eureka Drive, NewarkCost: The seminar is free of charge, but registration is required for planning purposesTo Register, visit http://www.acteva.com/booking.cfm?bevaid=177803 by Wednesday, November 4 at noonOn-Site registration: A limited number of on-site registrations may be available

Topic DescriptionTelevision shows from House to General Hospital include scenes where magnetic resonance imaging (MRI) is used. Indeed, chances are that you or someone you know has undergone MRI testing. Despite the number of people exposed to this technology, very few would be comfortable explaining how it works. As with many such technologies, even fewer would be able to describe in any detail how it came about. In fact, most of those who design and build MRI machines know little about its history.

This presentation will briefly review the basic ideas underlying MRI and then walk through the fascinating story of how Paul Lauterbur came up with the initial idea. Some of the intrigue and controversy surrounding the early days will be discussed. The development history of MRI provides a compelling look at the past and perhaps a window into future advanced technology development efforts.

Speaker BioWaldo Hinshaw has been working in the field of medical imaging for many years. His PhD research in the University of North Carolina Physics Department involved NMR (nuclear magnetic resonance) relaxation time

2 5/6/2023

measurements of various materials. After hearing about the first MR images during a lecture in Bombay in 1974, he returned to his lab in Nottingham and modified an NMR system so that it produced the second set of MR images.

He accepted an appointment as Associate Professor at Harvard Medical School with the goal of developing a clinical imaging system. It soon became clear that an industrial environment is better for developing state-of-the-art technology. He assembled a group within the Cleveland company, Technicare, which was the first company to ship significant numbers of clinical systems. Currently, he is working for Triple Ring Technologies and involved with other nascent imaging technologies.

**********************************************************************

NCC ACRP, Thursday Evening, Nov. 5, 2009

Event:   Northern California Chapter Holiday Event: Dinner, Networking, including NCC ACRP Board Elections, Bylaws Approval, & Year in Review AND“Careers in Life Sciences 2009” Speaker: Toby Freedman, Ph.D., Synapsis SearchDate and Time:: Thursday, Nov. 5, 6-9 pmAgenda:         6:00 – 7:00 PM Registration sign-in, Networking, & Dinner Buffet7.00 -8.00 PM: President's Welcome, Volunteer Certificates of Appreciation, Board elections, Bylaws revision, Raffles, Announcements                    8.00 - 8.50 PM: Presentation 8.50-9.00 PM: Continue Q&A, networking; complete & turn in board ballots and bylaws votes. Location:Menlo Park VA, Auditorium Room B-200; Building 334, 795 Willow Road, Menlo Park,  CA  94025 EVENT REGISTRATION through Monday, 02 November 2009   Register early to assure admission; at event IF space available REGISTER  NOW --CLICK ON REGISTER NOW! NCC ACRP Member  Free ACRP Member   $10 Non-ACRP Member $15 Non-ACRP Member Walk-in $20 Contact hours are not offered for this event Instructions for Event Attendees NCC ACRP registration / purchase refund policy: no refunds. No transfers. Membership not required for online registration. Questions? Renisa Satrijo at rsatrijo@gmail.comProgram Description 2009 has been a year of year of surprises and challenges for the life sciences industry. What will 2010 bring? Our presenter will summarize the current landscape including - current trends in biotech, the future remains promising, what are the hot jobs, and why we're motivated to work in this industry.  She'll also review career planning and development approaches - personality attributes for successful careers, job search strategies, how to identify your ideal job, and moving up the career ladder.

Speaker Bio Toby Freedman is an author and Founder/President of Synapsis Search.  A scientist by training, she transitioned into business as a recruiter, writer, and entrepreneur.  Her book Career Opportunities in Biotechnology and Drug Development provides a comprehensive overview of the many careers in the life sciences industry ranging from venture capital to marketing to discovery research. She recently started her own recruiting firm, Synapsis Search, which is focused on executive R&D and business placements in the life sciences industry. She previously worked at BioQuest, an executive search firm, and as Director of Business Development at SLIL Biomedical, a drug discovery company developing therapeutics for cancer and other diseases. She earned a Ph.D. in molecular biology from UNC Chapel Hill, a B.S. from the University of California, and as an NIH

3 5/6/2023

Fellow, conducted postdoctoral research at Harvard University and at the University of Texas-Austin. Toby is the Program Chair for the BioScience Forum, a leading non-profit educational forum serving the Bay Area biotechnology community and teaches career development for the life sciences at UC Berkeley Extension.

Target Audience:

Clinical Research Professionals Sponsor Organizations Study Site Investigators & Coordinators Independent Consultants Students of Clinical Research Academic Medical/Clinical Researchers Service Providers/Vendors Institutional Review Boards Quality Assurance

Directions to the Menlo Park VA Auditorium From 101, take the Willow Road exit going west Turn RIGHT at the second stoplight, entering the VA grounds Turn RIGHT at the stop sign onto Hospital Plaza Turn LEFT at the stop sign onto Redwood Ave Bldg 334 will be on your left; Park in Lots 334 or 323 Take the elevator or stairs to the 2nd floor of Bld 334 The speed limit is 15MPH!

*******************************************************************

Fountain Blue’s Funding Road Trip, Friday Morning, Nov. 6, 2009

FountainBlue's Funding Road Trip: “Perfecting Your Pitch to Investors”Date and Time:        Friday, November 6, 8:30 a.m. - 1:30 p.m.Agenda for the Pitch Workshop:8:30    Registration and Networking9:00    Bill Joos: Perfecting Your Pitch to Investors10:30  Morning Break 10:45  Pitch Practice Sessions - 6-10 teams, 15 mins a team, no official break for lunch1:00   Optional Pitch Debrief Meeting Facilitated by Bill Joos1:30   Adjourn. Please note that we have the room until 1:45 p.m. and we welcome you to stay to network fellow entrepreneurs.Location: Cooley Godward Kronish, LLP, 3175 Hanover Street in Palo AltoAudience:  Early-Stage, Funding-Bound Clean Energy, High Tech and Life Science No Service Providers, PleaseCost for 2 Entrepreneurs: $80 for FountainBlue members, $85 for Partners, $90 General, $100 On-Site. An additional fee of $4-$5 will be added for processing.Registration: Please pre-register by noon on 11/4 using the PayPal link at http://www.fountainblue.biz/fundingroadtrip.html. Late and on-site registration is $100 if e-mail is time stamped after that, regardless of membership status.

 About the Funding Road Trip Series:

These events are for Silicon Valley-based high tech, life science and clean energy entrepreneurs from the FountainBlue community and beyond.

The interactive and collaborative nature of this initial workshop requires two representatives from each start-up company to attend.

4 5/6/2023

Attendance at one of the first two workshops in the series is a pre-requisite for attending the final workshop, which features a presentation to active investors.

Additional representatives from the same company may attend for a nominal additional fee. Each session will start at 8:30 a.m. and end between noon and 1 p.m. Space is limited so we strongly suggest early pre-registration.  No service providers are allowed, unless they are invited speakers or current sponsors.

For more information about FountainBlue's Funding Road Trip Series including testimonials and speaker bios, please visit http://www.fountainblue.biz/fundingroadtrip.html.

Topic DescriptionFountainBlue cordially invites high tech, life science and clean energy entrepreneurs to the second funding preparation workshop entitled Perfecting Your Pitch to Investors. This hands-on workshop, the second in the FountainBlue Funding Road Trip series, will take entrepreneurs through the process of creating and delivering a compelling elevator pitch, a one-page executive summary and a 13-15 slide company overview presentation. Working in partnership with fellow entrepreneurs in similar, non-competing spaces, participating entrepreneurs will have the opportunity to learn best practices and immediately apply these learnings to their own companies. Whether you are a serial entrepreneur, or someone who may be considering a future opportunity, you are sure to benefit from the information presented, the connections made and the peer-to-peer knowledge shared.

Speaker BioBill Joos is the principal of "Go To Market Consulting", based in Palo Alto, CA. He works with early stage startups, venture capital firms and their portfolio clients. Most recently he spent 6 years as the VP of Entrepreneur Development at Garage Technology Ventures, an early stage venture capital firm that he co-founded along with Guy Kawasaki. His reputation at Garage was that he provided their clients with effective, hands-on, action-oriented strategic and tactical mentoring and coaching. Bill has worked with literally hundreds of early-to-mid stage startups and helped them polish and clarify their messages and refine their fund-raising and customer presentations; but his contributions to them extended well beyond being a "Pitch Doctor". He has mentored and coached them in go to market strategies, revenue and pricing optimization, business alliances, business development, partnerships, and marketing. Over 15,000 entrepreneurs worldwide have attended conferences where Bill has been a featured keynote speaker on various entrepreneurial topics. He has held sales and marketing positions with a variety of companies, including IBM and as a VP of the software division of Apple Computer.

*************************************************************************************

QED@QB3, Berkleley, Friday, Nov. 6, 2009

Topic: “Navigating the Life Science Venture Industry”Speaker: Jon Norris, Managing Director at SVB CapitalDate and Time: Friday, Nov. 6, 2009, 12:00 noon – 1:00 pmLocation: Stanley Hall Room 621, UC Berkeley

Date: Friday November 6, 2009 Time: 12:00 noon – 1:00pm Location:

Lunch provided, but space is limited so please reserve a seat here. http://www.acteva.com/booking.cfm?bevaid=189206

Topic DescriptionWhat’s the current state of the venture industry, and what are recent investment trends and areas of recent investments? Jon Norris, Managing Director at SVB Capital, will address how to best position you company to take advantage of these changes and trends.Speaker Bio

5 5/6/2023

Jon Norris is a managing director with SVB Capital’s Private Equity Group, specializing in life sciences. Norris has more than seven years of banking experience focused on working with life science companies and venture capital firms. He is responsible for strengthening relationships with select venture capital firms by leveraging SVB’s platform of strategic business units, including investment and commercial banking, as well as global and analytical services.  Prior to joining SVB Capital, he was a founding member and senior vice president of Square 1 Bank, an early stage technology bank. Norris also served more than six years at Imperial Bank (subsequently acquired by Comerica Bank), most recently as senior vice president and group manager of the Northern California Life Science Practice.

***************************************************************************************

UCSC Extension Course, Two Saturdays, Nov. 7 and 14, 2009

Course Title:  Regulation of Biomedical Products Advertising, Promotion, and Labeling (Course Code: 20756-005)Dates & Time: Saturdays, Nov. 7 & Nov. 14, 2009, 8:30AM to 5:00PM Where:  UC Santa Cruz Extension, Santa Clara Campus New Location:  2505 Augustine Dr, Santa Clara, CASpeaker (s) – Joyce L Chiarenza, Instructor, and one guest speaker Cost:  $560 Tuition

Registration:  ucsc-extension.edu (Biosciences/Regulatory Affairs

Course Description:The biomedical industry offers numerous examples of what not to do when it comes to advertising, promotion, and labeling. Drawing on real-world cases in the public domain, this workshop-format course unravels the mysteries of advertising and promotional regulations and guidance documents, and provides hands-on experience with their interpretation and practical application. Participants learn what gives regulators the grounds to take action on violative materials, and they gain an appreciation of the risk levels inherent in various promotional strategies. The instructor highlights the dynamic between regulatory professionals and the marketing, medical communications, and corporate communications departments, and offers tools for effective partnering around their joint advertising, promotion, and labeling activities. This course will benefit regulatory, medical, legal, marketing, and sales professionals responsible for the review of materials used in the promotion of prescription and OTC drug, biologic, medical device and diagnostic products.

 Instructor Background Joyce L. Chiarenza, B.S., has 39 years of experience in the pharmaceutical and biotech industries, during which she has held senior positions in quality control, quality assurance, compliance and regulatory affairs. After more than 16 years at Genentech, Inc., she began her consulting practice, where she specializes in labeling, advertising and promotion. Joyce also held several quality positions with Abbott Laboratories and has experience with vitamins, food supplements and cosmetics.

**************************************************************

UCSC Extension in Silicon Valley, Clinical Project Management, Saturday, Nov. 7, 21 & Dec. 5, 2009

Course:”Clinical Project Management”Instructor: Liz Wool, BSN, CCRA, CMTDates and Time: Saturdays, Nov. 7, Nov. 21 and Dec. 5, 9:00 am – 5:00 pmLocation: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053, (408) 861-3700Registration: Tuition - $645; Early Enrollment Fee:

6 5/6/2023

www.ucsc-extension.edu/biosciences for course descriptions and links to all of our bioscience certificate programs. Questions? E-mail biosciences@ucsc-extension.edu or call 408-861-3860.

Course Description:This course addresses critical elements in the effective planning and management of clinical trials. Exercises and case studies illustrate how to develop and manage activities, timelines and budgets; examine staffing and resources requirements; and lead and motivate effective teams. The strategic development plan, team and site performance problems, and post-marketing studies are also discussed. This course will benefit clinical research professionals with a solid foundation in drug development, GCP and monitoring who are beginning to manage clinical trials.

Instructor Bio

Liz Wool, B.S.N., CCRA, CMT, is president and CEO at QD-Quality and Training Solutions, Inc., a consulting firm providing clinical quality systems and training services to sponsor companies, CROs, and investigational sites involved in clinical research. She has more than 30 years of experience in the healthcare arena, including 18 years in the product development industry inclusive of positions in biotech and pharmaceutical companies, investigational sites, CROs, and academia. Her areas of expertise include quality and compliance, quality systems development and process improvement, clinical trial management, managing studies at investigational sites, as well as establishing and managing clinical development training departments in local biotechnology and pharmaceutical companies. She supports the Association of Clinical Research Professionals (ACRP) by serving as vice president of the Northern California Chapter.

************************************************************************************

UC Berkeley Extension Career Course, Saturday Afternoon, Nov. 7, 14 & 21, 2009

Event: “Career Opportunities in Biotechnology and Drug Discovery”Instructor: Toby Beth Freedman, Ph.D, Principal, Synapsis Search and Author, Career Opportunities in Biotechnology and Drug DevelopmentDates and Time: 3 meetings, Nov. 7–Nov. 21: Sat., 1–6 pmLocation: Redwood City: Peninsula Center, 1991 Broadway St.

Enroll Nowwww.unex.berkeley.edu(510) 642-4111Cost: $750 (EDP 401729)

Course DescriptionIdentify a biotechnology career path that best suits your interests, skill sets, and career goalsin this one- or three-day course (depending on location). Develop an understanding of avariety of career paths in biotech including venture capital, sales and marketing, businessdevelopment, clinical and regulatory affairs, and project management. You also get practicaljob search advice on topics such as informational interviews, résumé writing, networking, andinterviewing strategies.

Speaker BioToby Beth Freedman, Ph.D., is the author of Career Opportunities in Biotechnologyand Drug Development and owner of Synapsis Search, a life sciences recruiting company.She has a Ph.D. in molecular biology from UNC Chapel Hill.*******************************************************************************

*******************************************************************************************************

7 5/6/2023

BioSpace DeviceSpace Career Fair, Monday, Nov. 9th in Irvine

Event: DeviceSpace Career FairDate and Time: Monday, November 9, 2009, 1pm to 6pmLocation: Marriott Irvine, Irvine, California

Event Description\BioSpace is proud to present the DeviceSpace Career Fair, an opportunity for leading medical device & diagnostics companies to meet face-to-face with job seekers. Do not miss the chance to interview with the medical device industry's most prestigious companies!

All candidates must have at least a four-year college degree and two years of industry related work experience to attend. (Equivalent work experience may be considered in lieu of a four-year college degree.)Qualified candidates will receive their invitations and confirmation numbers via email no later than 72 hours prior to the career fair. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event.Click here to pre-register now.We look forward to seeing you at the DeviceSpace Career Fair!BioSpace Career Fair Teamcontactus@biospace.com ************************************************************************************

Bay Bio Medical Device Breakfast, Tuesday Morning, Nov. 10, 2009

Topic: Medical Device Breakfast Series “The Product Development Process”Moderator: Mally Arad, Manager, Project Planning & Execution, Integrated Project Management CompanyPanel Speakers: Liz Lison, Regulatory Affairs ConsultantAdvocea LLC John Howard, P.E., Vice President , Research and Development, Intuity Medical Dennis F. Marr, Ph.D., PMP, Sr. Director, Research and Development, Thoratec Corporation Jonathan Morris, Ph.D., QA Director, Endovascular Innovations, Medtronic CardioVascular Denise Zarins, Vice President, Research and Development, Ardian Inc.Time and Date: Nov. 10, 2009, 8:00 -10:00 amLocation: Cooley Godward Kronish LLP, Palo Alto Campus, 3175 Hanover Street, Palo Alto, CA 94304

Early Bird Registration through Nov. 7:$10.00 - BayBio & MDMA Members, Bio2Device and Bio-X Affiliates$20.00 - Non-MembersOn-Site Registration, Nov. 10:$20.00 - BayBio & MDMA Members, Bio2Device and Bio-X Affiliates$40.00 - Non-Members

Register at http://www.acteva.com/booking.cfm?bevaid=190875

Topic DescriptionProduct development delays mean prolonged timelines and missed launch dates, which result in budget shortfalls, stunted fiscal growth, even potential company failure. At best, the impact of a delayed product launch is lost revenue and market share opportunity. As the economic climate has become more challenging, the need for a formal, flexible, and proactive development process has become key to a company’s success. Adherence

8 5/6/2023

to such a process maximizes efficiencies and facilitates speed-to-market while ensuring FDA and ISO compliance, but implementation and ongoing execution can be challenging. This panel will examine potential issues inherent in the creation of a robust and formal product development process (PDP) and the operational framework necessary for its success. Panelists from several medical device companies will share tips on anticipating and conquering challenges and common pitfalls, based on their own experiences.****************************************************************************************

Bio2Device Group, Tuesday Evening, Nov. 10, 2009

Topic : “Acquire and Fire! Utilizing robotics and image guidance to annihilate cancer”Speaker: Michael Saracen, Director of Product Development for IGRT & Robotics at Civco Medical SolutionsDate and Time: Tuesday, Nov. 10, 2009, 6:00 – 9:00 pmLocation: Location: TIPS Group Law Offices , 1000 Elwell Court, Palo Alto, CA 94303Advanced registration is required: See www.bio2devicegroup.org website a week prior to event for preregistration detailsCost: Fee for light dinner with range depending on timing of registration:

Topic DescriptionRobots are commonplace in many industries today demonstrating the benefits reliability, precision and accuracy have to offer. Medicine is starting to embrace technology, realizing some tasks are performed better and in some cases better performed by a machine. One area which has greatly benefited from this marriage of technology and medicine is Radiation Oncology. Targeting tumors inside the body with high precision and accuracy throughout a treatment is challenging, often requiring immobilization devices to prevent the patient from moving. The problem becomes significantly more difficult when treating tumors that move with respiration like those found in the lung, liver or pancreas. One system, the CyberKnife, has successfully integrated robotics into patient setup and delivery of radiation, making treatments safer and more precise. Leveraging fully integrated image guidance capabilities, the system automatically adapts to movements and changes in the patient’s breathing patterns without user input. Robotics has a place in medicine, the question is, to what extent does it improve patient care and can reduce costs in the long run.

Speaker BioMichael Saracen is the Director of Product Development for IGRT & Robotics at Civco Medical Solutions. He has over 15 years experience creating, patenting, developing and launching new products and services into the medical device industry. Prior to Civco Michael worked at Accuray Inc. as director of product management and product marketing departments overseeing all aspects of the product lifecycle. Before Accuray, Michael worked in three different medical device companies overseeing their Image Guided Surgery product lines. He has extensive experience in robotics, biomaterials, radiation delivery and medical software systems. Michael received his Masters from Brown University in Biomaterials and Artificial Organs. Prior to getting his masters he worked in protein biochemistry research in the Orthopedic Department at Rhode Island Hospital.

While at Accuray Michael was a lead inventor on the RoboCouch, a fully robotic patient positioner, and took the product from concept to prototype in 6 months and received FDA clearance within 9 months. Michael has 9 issued and 10 pending patents covering robotics, quality assurance, tracking & vision systems and treatment planning software.

***************************************************************************************

SF AWIS, Wednesday Evening, Nov. 11, 2009

Topic: An Overview of the Patent Process :From Conception to Issuance Speakers: Geri Rochino, JD and Shelley Eberle, JD

9 5/6/2023

Date and Time: Wednesday, November 11th, 2009, 6:30 to 8:30 pmLocation: Amgen, 1120 Veterans Blvd, South San Francisco

Topic DescriptionGeri Rochino, JD and Shelley Eberle, JD as share stories from their professional career path.

Speaker BiosGeri Rochino, JD.: Prior to joining Mintz Levin, Geri served as a patent attorney at an intellectual property law firm in East Palo Alto. Her practice included various technologies, including biotechnology, medical devices, biosensors, drug delivery systems and nanotechnology. She has drafted patent applications, FTO opinion letters, prosecution history summaries and responses to USPTO office actions.

Shelley Eberle, JD.: Prior to joining Mintz Levin, Geri served as a patent attorney at an intellectual property law firm in East Palo Alto. Her practice included various technologies, including biotechnology, medical devices, biosensors, drug delivery systems and nanotechnology. She has drafted patent applications, FTO opinion letters, prosecution history summaries and responses to USPTO office actions.Cost:: $8.50 members, $17 non-members, $25 after registration date Register via ACTEVA by Monday, November 9th http://www.acteva.com/booking.cfm?bevaID=192556&CFID=11390188&CFTOKEN=73256457Parking is free

All scientists, students, and friends are welcome.For additional information check http://www.sfawis.com/

*****************************************************************************

Golden Gate Polymer Forum, Thursday Evening, Nov. 12, 2009

Topic: "Polymer and Pharmaceutical Materials Characterization Under Dynamic Humidity Atmospheres" Speaker: Steven R. Aubuchon, TA Instruments, Newcastle, Delaware

               Discounted Early Registration Ends 5pm Wed. Nov. 4

Date and Time: November 12,

Timing:       6:00 PM  social hour                  7:00 PM  dinner                  8:00 PM  presentation

Location: Michael's at 2960 N Shoreline Blvd. , Shoreline Park, Mountain View   http://www.michaelsatshoreline.com/location.html

Dinner Selections:        Salmon         Chicken portobello         Grilled vegetable brochette

Cost:   Employed/postdocs:  $30 with advance registration, $35 normal registration          Unemployed/retired/students:  $15 with advance registration, $20 normal registration            After deadline:  registration not guaranteed, so contact us                     late fee applies -- $40 regular/employed, $25 unemployed/student/retired           Free if you attend just the lectures at 8:00 PM (but please let us know for headcount)

Deadline for registration:    5 pm Nov. 11 (but please try to do so earlier if you can; it helps)

10 5/6/2023

Early Registration Ends 5pm Wed. Nov. 4.Because we must pay the restaurant for the ordered meal, we must ask no-shows to pay for their reservation.  

PLEASE NOTE:  we accept cash or checks, but are unable to accept payment by credit card at this time.   You may pay at the door.

Please register on the web page              www.GGPF.org

Or, if necessary, contact:        Len Radzilowski         lradzilo@tycoelectronics.com         650-361-3264

You should receive confirmation of your registration; if not, please contact us again.                        

Topic DescriptionTraditional thermal analysis experiments were typically performed under inert atmospheres, with limited consideration of the effects of reactive or humid atmospheres.  However, in practice it is virtually impossible to eliminate water from processing, storage or end-use of most materials.  As such it is important to create and control dynamic atmospheres, and to measure thermal and mechanical properties taking into account the effects of water.  Modern instrumentation now provides for the simultaneous direct control of both temperature and relative humidity, applied to both gravimetric and dynamic mechanical analyses.  In this seminar, moisture sorption analysis will be introduced and discussed, as it relates to a wide range of organic and polymeric materials whose applications include pharmaceuticals, electronics, fuel cells, and packaging.  Detailed examples from both gravimetric and dynamic mechanical analysis applications will be presented and discussed.

Speaker BioSteve Aubuchon is Product Manager for TA Instruments-Waters, LLC.  He has been with TA Instruments since 1994, holding positions in applications, product development, technical support and sales.  Steve earned a Ph.D. in inorganic physical chemistry from Duke University and a B.S. in chemistry from St. Louis University.  He has authored over 30 literature publications and has presented invited lectures, seminars and training courses in the field of thermal and mechanical of materials in over 20 countries worldwide.  

In addition to his work at TA Instruments, Steve holds an appointment as Adjunct Professor of Chemical and Life Sciences Engineering at Virginia Commonwealth University in Richmond, Virginia (USA).

*******************************************************************WCC PDA, Thursday Evening, November 12, 2009

Topic: "A Revised Vision for Effective Enforcements and Benefits to the Public Health"

Speaker: Mark S. Roh, Regional Food and Drug Director, Pacific Region, FDA Date and Time: Nov. 12, 2009 | 6:00 – 9:30 PM 6:00 PM Registration, Networking Hour 7:00 PM Banquet Buffet Dinner 7:45 PM Announcements 8:00 PM Presentation and Discussion 9:30 PM ClosingLocation: Dominic's at Oyster Point| SSF, CA Registration - Reserved Seating is Limited to the First 100 Registrants! Submit registration requests via e-mail to rsvp@wccpda.org with "WCC PDA November Dinner RSVP" as the subject line. Indicate name and company affiliation for each registrant. Seating is limited to the first 100 registrants! It is strongly encouraged that you register in advance to ensure seating at this event, and to allow us to provide an accurate head count for meals.

11 5/6/2023

Pricing Policy Pre- Registration $ 65.00 (Credit/Cash/Check); Walk- Ins/At Door $ 75.00 (Cash/Check Only) There is a $15 Discount for Government Employees and Students. Payment Options WCC PDA uses PayPal® to process all credit card payments. Access PayPal directly from the chapter website at www.wccpda.org (click the "Events" button and scroll down to the PayPal link). You do not need a PayPal account to use the online payment service and there is no additional fee for registrants. For check payments, you can use the PayPal service or make paper checks payable to "WCC- PDA." If you experience difficulty with the PayPal link, contact the webmaster. Cancellation Policy Dinner seating is confirmed and reserved in advance. We regret that no refunds can be offered for non- attendance. If a registrant cannot attend, substitutions are welcome.

Topic overview In August 2009, Commissioner of the Food and Drug Administration Margaret A. Hamburg, M.D., outlined her commitment ìto prevent harm to the American people through swift, aggressive, and effective enforcement of FDA laws and regulations, and highlighted six initial steps designed to hone the effectiveness and timeliness of the FDA's regulatory and enforcement system: Set post-inspection deadlines. Take responsible steps to speed the warning letter process. Work more closely with FDA's regulatory partners. Prioritize follow-up on warning letters and other enforcement actions. Be prepared to take immediate action in response to public health risks. Develop and implement a formal warning letter "close-out" process.

Mark Roh, Director of FDA's Pacific Region, will discuss this revised vision for effective enforcement and its affect on public health and the industry at this West Coast Chapter PDA Meeting.

Speaker BioMark was appointed by the FDA Commissioner as Regional Food and Drug Director in August 2008. Prior to that, Mark had been Acting Regional Food and Drug Director since April 2006. As Regional Director he is responsible for the daily management of FDAís Pacific Region that includes the three Districts and two Regional Laboratories that comprise the Pacific Region, over 800 employees and all FDA regulatory and related programs within the nine western states and pacific island territories. Markís duties include implementation of national policy and development of local policies and policy and operation coordination and cooperation with other Federal and State agencies responsible for FDA regulated product. From 1999 to 2006 Mark served as Deputy Regional Director and Special Assistant to the Regional Director. Prior to serving in the Office of Regional Director, Mark was the Small Business Representative and administered the Small Business Assistance Program in the nine states of FDAís Pacific Region from 1990 to 1999. The Office of Small Business Assistance assists regulated industry to achieve voluntary compliance with laws and regulations enforced by the Food & Drug Administration. Prior to becoming the Small Business Representative, Mark was a FDA Investigator for 12 years, specializing in biologic products, medical devices and clinical research. During his tenure at FDA, Mark has received numerous awards for outstanding achievement, including the Commissionerís Commendable Service Award and Special Citation, the Agencyís Award of Merit and the Vice Presidentís Hammer Award. Mark holds academic degrees in Education, Zoology and Chemistry. Sponsorship

www.wccpda.org Serving the Bay Area, Northern California, and Beyond ********************************************************************************UCSC Extension in Silicon Valley, Molecular Diagnostics, Nov. 13-14, 2009

Course: Molecular DiagnosticsDate: Friday and Saturday, Nov. 13-14, 2009, 9:00 – 5:00 pmLocation: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053, (408) 861-3700

12 5/6/2023

Registration: Tuition - $525; early enrollment $472.50 through Oct. 30www.ucsc-extension.edu/biosciences for course descriptions and links to all of our bioscience certificate programs. Questions? E-mail biosciences@ucsc-extension.edu or call 408-861-3860.

Course DescriptionRapid advancements in molecular diagnostics are drawing the attention of the bioscience industry, regulatory agencies, clinicians, patients and insurers alike. This survey course provides a foundation in the basic science and technologies that underlie the emerging field of molecular diagnostics, and highlights the potential impact on the health care landscape. Interactive lectures explore the intricate relationship between the human genome and diagnostic tests. The instructor addresses the growing importance of personalized medicine, and touches upon the role of pharmacogenomics in the development of new therapeutics and treatment options. He uses case studies to present the applications of molecular diagnostic tools in infectious disease identification and early detection and diagnosis of cancer. Also addressed are the regulatory challenges that face the new wave of diagnostic tests, and the changing dynamics of the molecular diagnostics global marketplace.

Instructor Background

Binaya Panda, Ph.D., is the co-founder of a molecular diagnostics startup company that focuses on genetic tests for cancer. He previously worked for Affymetrix, where he managed alliances. Dr. Panda earned his Ph.D. at the University of Oxford, and received post-doctoral research training from the Scripps Research Institute.

***********************************************************************************San Francisco Chapter of RAPS, Friday Afternoon, Nov. 13, 2009

Topic: “The Revised EU Medical Device Directive Requirements for 2010: Is Your Company Ready?”Speaker: Keith Morel, PhD, senior project manager and lead auditor, KEMA MedicalDate and Time: 13 November 2009, 12:00pm–3:30pmLocation: Hyatt Regency Santa Clara, Santa Clara, CACost: List - $100; Members - $80

Register Today! http://www.raps.org/personifyebusiness/Bookstore/ProductDetail/tabid/55/Default.aspx?ProductId=6082

Topic DescriptionJoin regulatory colleagues from the Bay Area for an afternoon of networking and an expert presentation entitled, “The Revised EU Medical Device Directive Requirements for 2010: Is Your Company Ready?” This event is sponsored by the RAPS San Francisco Chapter and is intended to promote knowledge advancement and facilitate networking among local regulatory professionals.

With the March 2010 deadline fast approaching, many companies are scrambling to meet the new requirements of the revised EU Medical Device Directive (MDD). Join experts from KEMA for an interactive session that highlights the most critical changes to the EU MDD and addresses, in practical terms, the challenges firms are facing with their interpretation. Learn what the expectations are, from a Notified Body’s perspective, and gain practical insight into implementing the revised MDD.

A luncheon will be available for all meeting registrants and participants may claim three RAC recertification points.

*****************************************************************************Taiwan Overseas Recruiting Event in Silicon Valley, Friday & Sat., Nov. 13 – 14, 2009

13 5/6/2023

Event: HiRecruit Job Fair 2009Date and Time: Friday Nov. 13, 2:00 - 8:00 pm & Saturday Nov. 14, 9:30 am - 5:00 pm Location: Hyatt Regency Santa Clara, 5101 Great America Parkway, Santa Clara, CA 95054, View job openings and sign up for 1-on-1 job interviews:  Please register at http://hirecruit.nat.gov.tw/english/tour_JobList.asp Investment in Taiwan http://www.investintaiwan.org.tw/Taiwan Exporters & Industry Newsletters  http://www.taiwantrade.com.tw/

Event Description All talents are invited to meet face to face with leading international companies and research institutes from Taiwan.  Over 200 job openings in technology related fields are available for job seekers to apply.  Come to HiRecruit Job Fair and see how your career can be transformed!      ************************************************************************************************************

CBA, Saturday Afternoon, Nov. 14, 2009

Topic: “Annual Conference: Emerging Trends in Biotechnology Industry” Date and Time: Sat, Nov 14, 2009, 1:00- 5:30 PMLocation: Double Tree Hotel San Jose 2050 Gateway Place, San Jose, California 95110

Online registration: Oct 3 - Nov 12, 11:30 PM Please check our website for details and register now at www.cbasf.orgOn site registration: Starts at noon, Nov 14. Seatings will be very limited for on site registration.

Conference: Dinner with seminar: Starts at 6:30 PM at the same location

For CBA Members:     Conference Only          Free   Conference and Dinner    $50For Non CBA Members and Students/Postdocs:   Conference Only          $10   Conference and Dinner    $60For Other Non CBA Members:   Conference Only          $20   Conference and Dinner    $70   CBA will pay for the parking at Double Tree Hotel.

Program Description

The theme of the conference is “Emerging Trends in Bioscience Industry”, with an array of scientific experts and business development leaders presenting the latest information on emerging biotechnological development and business opportunities around the world. .  Annual conference program12:00 – 1:00  Registration 1:00 – 1:15     Welcome & Opening Remarks                        Ms. Stella Chang, CBA President

Dr. Sydney Chen, Program Chairperson                     

14 5/6/2023

1:15 – 2:00     Bioscience: New Technology and Industry OutlookMr. Matthew GardnerPresident  & CEO, BayBioModerator:  Dr. Katy Korsmeyer

2:00 – 2:45     Stem Cell Application in Regenerative Medicine Dr. Jane LebkowskiSenior Vice President & CSO, Geron Corp    

                        Moderator: Dr. Shian-Jiun Shih2:45 – 3:00     Bio Fuel: Bioprocessing

Ms. Wei HuangVice President, LS9 Inc

                        Moderator: Cesar Ho3:00 – 3:20     Coffee Break3:20 – 5:20     Panel Discussion

Bridging US-Asia Biopharmaceutical Industry: Overview, Opportunities and Challenges

                        Chairperson: Dr. Jing-Shan HuDirector Licensing and External Research, Merck & CoDr. Larry Hsu, President, CEO & Director, Impax Laboratories

                        Dr. Jo Shen, President & CEO, ScinoPharm                        Dr. Marietta Wu, General Manager Greater China, Burrill & Company5:20 – 5:30     Closing Remarks                        Dr. Sydney Chen, Program Chairperson          5:30 – 6:00     Networking 6:00 – 9:30     Dinner

Keynote : Prof. Ginger Cheng-Chi Hsü 徐澄琪教授Department of the History of Art, UC-Riverside

******************************************************************************************

Fountain Blue Life Science Forum, Monday Evening, November 16, 2009

Topic: Personalized Medicine, Biomarkers, Invitro Diagnostics: The ScienceAdvances, The Business Opportunities, The Cultural DilemmasDate & Time: Monday, November 16 from 5:30 - 7:30 p.m. Location:    UCSC Extension in Silicon Valley, 2505 Augustine Drive, Suite 100, Santa Clara*   

Facilitator Linda K. Molnar, LKM Strategic Consulting·           Panelist Doug Dolginow, PhD, BOD, Advisor, Founder CSO/CMO, Veracyte, Inc, and CEO and BOD, NanoValent·           Panelist Ted Driscoll, Venture Partner, Claremont Ventures, Member, Life Science Angels·           Panelist from Applied Biosystems, a Life Technologies Company, to be confirmed·           Presenting Entrepreneur Richard A. Goozh, Sr. VP, Strategy & Finance, Wave 80 Biosciences·           Presenting Entrepreneur Dick Haiduck·           Another Presenting Entrepreneur to be confirmed, your recommendations and nominations for early-stage, funding-bound entrepreneurs are welcomeCost:                 $20 members, $30 partners, $40 general, plus a $1-2 fee.$100 plus fee for FountainBlue Ongoing membership, admission, and free giftRegistration:     Please pre-register by noon on 11/13 using the PayPal link at http://www.svlifescience.com.. Registrations received after the deadlinewill be applied to next month's event, unless you've registered for the $100ongoing or the $40 on-site payment, plus fees, regardless of membershipstatus. Audience:     Entrepreneurs, intrapreneurs and investors, no service

15 5/6/2023

providers pleaseFor more information and to register, visit http://www.svlifescience.com.

***************************************************************************************************

Bio2Device Group, Tuesday Morning, November 17, 2009

Topic: “Puzzles, Mysteries, and Complexities: Problem Solving in Life Science Organizations"Speaker: Jerry L. Talley, JLTalley and Associates and Deborah Lynne Lombardo, Executive Associate with Barnes & Conti AssociatesDate and Time: Tuesday, November 17, 2009, 8:30 – 10:30 amLocation: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA (across the street from Sunnyvale Public Library)Cost: FreeParking: On street and in NOVA and library parking lots across the street.

Topic DescriptionOn the door of every manager, project managers, or team leader an invisible sign that says "Bring your problems to me", or at least that's how people behave. –And in an industry characterized by innovation and research, you can be guaranteed a high volume of problems to solve. If you're lucky you have your team members to deal with their own problems.

Whether you work on your own or through a team,, your fluency in problem solving is a key component of your success. Dr. Jerry Talley (Professor of Sociology at Stanford University-retired) and Lynne Lombardo of Barnes & Conti Associates will share some new thinking in the art and science of problem solving that can give you a faster, more powerful way to think through the inevitable problems in any endeavor. Dr. Talley’s research over 10 years of examining business problems and how people solve them revealed that there are really only 6 types of problems and each problem has a best strategy for finding a solution. By accurately identifying the fundamental type of a problem rather than treating every problem with the same approach, you and your team members will save time, resources and increase good will -- not to mention fewer sleepless nights. Please join us to learn about the 6 problem types, the components of an ideal problem-solving group, and key skills you’ll need in your role as leader or facilitator.

Speaker BiosJerry L. Talley is a veteran of multiple careers. He started with 18 years on the Stanford University faculty in the department of Sociology. While there he also had a private practice as a Marriage Family Therapist for 10 years. And almost 30 years ago he moved into organizational development consulting. He has worked with over 300 clients in the Bay area, nationally, and some international. He has consulted to companies in high tech, pharmaceuticals, hospitals and health care, banking and finance, consulting houses, the military, manufacturing, public utilities, public sector, not-for-profits, publishing, hospitality, entertainment, and one organic grocery store. He specializes in strategic planning, non-profit governance, and advanced problem solving and decision-making. His practice is summarized on www.JLTalley.com.

Deborah Lynne Lombardo has more than 25 years’ experience in providing creative and practical approaches to developing high performance in organizations. At UCLA’s Anderson School of Management, she became convinced that the true challenge of any endeavor is to mobilize human talent, energy, and brilliance to achieve extraordinary results. This has been her focus ever since.

Lynne’s career has built a broad base of management, sales, and consulting experience that have benefited organizations on every continent except Antarctica. Her clients have come from nearly every sector of the economy: financial, manufacturing, high tech, communications, insurance, biotech/pharmaceutical, education, transportation, energy, health-care and not-for-profit theaters such as The Marsh and ACT in San Francisco. Her interest these days is on building high performance through better problem solving approaches; and helping companies to grow through innovative sales approaches.

16 5/6/2023

Among other affiliations, Deborah Lynne is an Executive Associate with Barnes & Conti Associates who has partnered with Jerry to bring his problem solving methodology to a wider audience. Learn more at www.barnesconti.com

*************************************************************************************

Palo Alto AWIS, Wednesday Evening, November 18, 2009

Topic: “10 Top Tips for Using Linked In Effectively”Speaker: Patrice Reid, Career Management Consultant,Right Management http://www.right.comDate and Time: Wednesday, Nov. 18 2009, 7:00 pm - 9:00 pm Schedule7:00-7:30 pm Networking and light supper7:30-7:45 pm Announcements7:45-8:45 pm Program8:45-9:00 pm Discussion

Location: Palo Alto Research Center (PARC), 3333 Coyote Hill Road, Palo Alto Directions to PARC.

For details and to register, http://www.acteva.com/go/pa-awis

Welcome!!  You don’t need to be a member to attend.All scientists, students, and their friends are welcome.  Men too!Members pay $5 and non-members pay $10 to offset the cost of food.

Topic DescriptionLinkedIn is the tool that people and organizations are using to connect and build relationships. For scientists, it provides a rich source of information on "who", "what" and "where" that can lead to new sources of collaboration, funding and career opportunity.How can LinkedIn and other social media tools like Twitter and Facebook advance your career? Among the topics we'll be covering are: profile completeness, expanding your connections, handling recommendations, joining groups, and posting status messages. This presentation will be particularly helpful if you are using LinkedIn but not really optimizing it.

Speaker Bio

Our speaker, Patrice Reid, is a Career Management Consultant with Right Management in San Francisco. Patrice specializes in providing career transition, workshop facilitation and career consulting services for both companies and individuals. Her specialties include startup/entrepreneurship coaching and the use of social media tools in career management.

Directions from 280:

Take Hwy 280 and exit at Page Mill Rd and go East towards Palo Alto (if coming from the South, turn right, if coming from the north, turn left onto Page Mill. Turn RIGHT onto Coyote Hill Rd. Turn LEFT into PARC (formerly Xerox PARC).  Follow signs to the Auditorium on your left at end of parking area, down flight of outdoor stairs.

Directions from Stanford: Take Foothill SOUTH towards Los Altos. Turn RIGHT on Hill view and PARC is 2nd driveway on the right. Park and follow signs to the Auditorium (walk uphill through parking lot then down a flight of outdoor stairs).

17 5/6/2023

See also http://www.tinyurl.com/PARC-Auditorium/   for map.For more info: www.pa-awis.org, or email awis.pa@gmail.com

**************************************************************************************

IEEE, Engineering in Medicine and Biology Society (EMBS), Wed. Evening, Nov. 18

Topic: “The development of the LATITUDE Patient Management System”Speaker: Ken Hoyme, Sr. Fellow – Systems Engineering, Boston Scientific – Cardiac Rhythm Management

Date and Time: Wednesday,  November 18, 2009,  7:30 pmNew location:  Room M-114, Stanford University Medical School Optional dinner, new location: Nexus Cafeteria in the Clark Center, 6:15 pm (no host, no reservations)

Topic Description   Patients who have implantable cardiac therapy devices (pacemakers and defibrillators) are required to make regular visits to a cardiac device specialist to ensure that the device is working properly, and optimized for that person’s specific needs. These visits can be a burden, both for the patient as well as their device physician, and the frequency of these visits are a balance between that burden and the benefit if a condition is detected that needs attention. More recently, cardiac resynchronization therapy has been shown to benefit patients suffering from heart failure, a disease that requires frequent monitoring to avoid recurring hospitalization. In-home remote patient monitoring systems have become the solution to these needs. The LATITUDE Patient Management System® was developed to address these needs for patients implanted with Boston Scientific’s implantable cardiac devices. This system has well over 100,000 active patients. This talk will focus on some of the key technical challenges in creating this system, including power management, safety, security and making this work within the workflow of a monitoring clinic.

Speaker Bio Ken Hoyme has over 25 year experience working in the systems engineering of complex, safety critical systems. His is currently Senior Fellow within the Cardiac Device Telematics group, responsible for defining the company’s future directions in patient management. He was the technical leader for the development of the LATITUDE Patient Management System. Prior to coming to Boston Scientific, Mr. Hoyme was a Senior Fellow at Honeywell’s corporate research center, where his research focused on safety critical control systems for commercial aircraft. Mr.Hoyme received his BS and MS in Electrical Engineering from the University of Minnesota. He is a member of the IEEE and is a Certified Systems Engineering Professional (CSEP) from INCOSE.  ****************************************************************************

Bioscience Science Forum, Wednesday Evening, Nov. 18, 2009 

Topic: "Infectious Disease Research in the 21st Century"Speaker: Hans Reiser, M.D., Vice President, Biology, Gilead Sciences, IncDate and Time: Wednesday, November 18th, 2009Time: 6pm Networking, 7pm Dinner, 8pm PresentationLocation: Location: The Clarion Hotel, 401 East Millbrae Ave., Millbrae, CARegistration is $50 ($35 for full-time students). Parking $4. On-site registration: add $10 to pre-registered price. Register online at www.acteva.com/go/biosf before Monday, November 16th, 2009 at 11:55pm.(We can only accept cash or checks at the door. There is an ATM machine in the hotel lobby.)Or you may pay with a check made out to  "BioScience Forum" and sent to    BioScience Forum    1442A Walnut St. #308    BerkeleyCA94709-1405Please do not mail checks later than Thursday, November 12th, 2009  Topic Description

18 5/6/2023

 Infectious diseases continue to afflict mankind. Infectious diseases are a leading cause of death both in the developed and in the developing world. In addition, infectious agents such as viruses and bacteria cause secondary mortality and morbidity, including cancer, autoimmunity and neurodegenerative disorders. Dr. Hans Reiser will discuss biomedical challenges facing human populations, including the need for more effective methods of detection, prevention of outbreaks and transmission, and for novel therapeutics. Focusing primarily on HIV/AIDS and viral hepatitis as examples, Dr. Reiser will describe key tools and approaches that are being developed to address these challenges.

Speaker Biography           Hans Reiser studied medicine (MD 1985; summa cum laude) at the University of Heidelberg, Germany. Upon graduation, he spent two years as a post-doctoral fellow in the laboratory of Baruj Benacerraf and Kenneth Rock at Harvard Medical School where he characterized the structure and function of murine Ly-6 proteins. In 1987, Dr. Reiser joined the faculty of the Harvard Medical School and began to characterize co-stimulatory molecules concerned with T cell activation. He generated the first antibody against mouse CD80, co-discovered a second member of the B7 family, and characterized the function of these proteins in the activation of antigen-reactive and T cells in a variety of animal models. This research was supported by grants from the National Institutes of Health and a Junior Faculty Research Award from the American Cancer Society. Dr. Reiser rose through the ranks and was ultimately appointed an Associate Professor (2004). He moved to Imperial College in 1996 as Professor of Molecule Immunology, where he continued his work on B7 molecules and also discovered the interaction between the CD48 and 2B4 receptors. His research in London was funded by grants from the Medical Research Council, the Wellcome Trust and the British Heart Association. In 1998, Dr. Reiser left academia for an appointment as head of immunology and inflammation research at Boehringer Ingelheim Pharmaceuticals in Connecticut, where he focused on the discovery of small molecules for the treatment of rheumatoid arthritis, Crohn’s Disease, multiple sclerosis, and psoriasis. In 2004, he joined Gilead as Vice President, Biology, where he has been predominantly involved in the discovery and development of compounds for the treatment of viral infections (HIV, HBV, HCV, HPV, respiratory viruses) and cancer. Dr. Reiser has published more than 60 research papers in leading scientific journals, including Cell, Science, The Journal of Experimental Medicine, and P.N.A.S. 

********************************************************************************

Bay Bio Therapeutic Breakfast, Thursday Morning, November 19, 2009

Topic: “Running a Virtual Company”Moderator: Carole-Lynn Glass, Director, Emerging Growth Services, RoseRyan, Inc.    Panel Speakers: William J Garner, MD, Chief Executive Officer, Urigen Pharmaceuticals, Inc. Barbara K. Finck, M.D., Senior Vice President, Research and Development andChief Medical Officer, Osprey Pharmaceuticals, U.S.A., Inc. Brian C. Cunningham, Senior Counsel, Morrison & Foerster LLP, CEO and DirectorClerigen Inc.Date and Time: Thursday, Nov. 19, 2009, 8:00 – 10:00 amLocation: Theravance, Inc., 901 Gateway Blvd., South San Francisco, CA, 94080Early Bird Registration through Nov. 17:$10.00 - BayBio Members$20.00 - Non-Members

On-Site Registration, Nov. 19:$20.00 - BayBio Members$40.00 - Non-MembersRegister online at http://www.acteva.com/booking.cfm?bevaid=188723

19 5/6/2023

Topic DescriptionAll companies face daily decisions about what to activities should be contracted out. For many life sciences companies, the answer has been virtually everything, from discovery to manufacturing to clinical trials. Management in such virtual companies rely on a network of contractors to perform these key functions. This panel explores how best to balance cost vs. control and the benefits and challenges of relying on contractors and consultants.*****************************************************************************************CABS Scientific Workshop, Saturday Afternoon, Nov. 21, 2009

Topic: “Preclinical Development and IND Filing: the nuts, bolts, and best practices” Speakers:Cuiping “Tracy” Chen, Ph.D., Director, PK, Depomed Inc.Linval Depass, Ph.D., Executive Director, Nonclinical Safety, Durect Inc.Bert Ho, Head, Ph.D., Pharmaceutical Development, ChemoCentryx Inc.Hua Mu, M.D. & Liang Fang, Ph.D., Genentech Inc. Date/Time: Sat., Nov 21, 2009; 12:30 – 5:30 PM (Check-in time: 12:30 – 1:00 pm) Location: UCSF Mission Bay, Genentech Hall Auditorium, 600 16th Street, San Francisco, CA, 94158 Fees: Online $1 for CABS members, $10 for non-members;          On-site: $5 for CABS members, $15 for non-members          Slide Handout: $10 (online only). Fees:– Online: $1 for members, $10 for non-members;– On-site: $5 for members, $15 for non-members

– Slide Handout: $10 (online only). Register at www.cabsweb.org

Topic Description

Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Therefore, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety, PK, CMC, and clinical plan is paramount.  In this workshop, our speakers highly experienced with IND filings will discuss systemically the preclinical studies required for small molecule IND filings and the nuts, bolts, and best practices for putting together a high-quality IND package, as well as how to interact with various regulatory agencies. Below are the topics to be covered:

- Overview of preclinical development and IND filing - Various preclinical studies required (Safety, DMPK & CMC) - Clinical Development plans - Interfacing with regulatory agencies including FDA

*****************************************************************************************Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009

Intensive Course: Bioscience Business Development: Building Value, Thursday and Friday, Dec. 3-4, 2009 ((2 days of classroom and 2 months to complete project guided by instructor)Instructors: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.comand and Gilbert R. Mintz, Ph.D., President of GRM AssociatesExpert Guest Speakers: Ginger Dreger, J.D., M.S., Goodwin Procter Harold (Hal) Etterman, MBA, Business Strategist Carolyn Feamster, MBA, VP, Business Strategy & Analysis

20 5/6/2023

Tom Gutshall, Chairman & Co-Founder of Cepheid Michael G. McCully, M.S., Director, Recombinant Capital Please see www.ucsc-extension.edu/biobizdev for complete biographies Date & Time: Oct. 8-9, 2009, Thursday and Friday, 8:30am-5pmLocation: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053Fee: $770; $693 through Nov. 19

Topic DescriptionUCSC Extension in Silicon Valley presents a two-day intensive course that brings the breadth of the Bay Area’s biobusiness development expertise to our Cupertino classroom. Whether financing start-up activities, trying to keep pace with the current burn rate, or moving a product into the marketplace, bioscience companies, both large and small, have a critical need for business development at every stage of their evolution. Learn the key roles that business development and licensing play in the commercialization of a new product and the development of a successful bioscience company. Santa Clara, CA. For more information, see www.ucsc-extension.edu/biobizdev

Instructor BiosAudrey Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.com has more than 35 years of marketing experience in the biotech and pharmaceutical industries, of which 25 years was in corporate management at Kowa Research Institute and Syntex Corporation.Gilbert R. Mintz, Ph.D., President of GRM Associates, a biotechnology consulting firm with expertise in business development, licensing and strategic planning.

**************************************************************************

San Jose Biocenter, Thursday Late Afternoon, Dec. 3rd, 2009

Topic: Trends in Financing Investor Panel & Holiday Celebration Invited speakers include:• Mike Powell, General Partner, Sofinnova Ventures• Sigrid Van Bladel, PhD, Partner, New Enterprise Associates• Casper de Clercq, Venture Partner, U.S. Venture Partners• Jennifer Fonstad, Managing Director, Draper Fisher Jurvetson• Doug Fisher, Principal, InterWest Partners LLC• Janis Naeve, PhD, Director, Amgen Ventures• Don Santel, Chief Executive Officer, Hyperion Therapeutics Date and Time: Thursday December 3, 2009 | 3pm-6:30pm Location: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park, CA 94025-1015Click here for Venue Directions»

This event is typically sold out, so pre-registration is recommended to avoid disappointment on the day!• Regular Price: $60• Partners' Network: $50• BioCenter Members: Free (please RSVP to Aurélie)• On-site Registration: add $10 to the above

Topic DescriptionSteady capital is a must for all companies.  The first step in funding is knowing where to look.  Join experts from the investment world to understand the types of financing that are occurring in your industry today, and what can be expected for 2010. Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Holiday Celebration Networking Reception.

21 5/6/2023

******************************************************************************************Northern California Analytical Chemists, Friday Lunch, Dec. 4, 2009

Event Name: Use of Nano Particle Technology to Enhance Performance of Pharmaceutical Products Speakers: Niels Ryde, Ph.D., Elan Drug Technologies Date and Time: Friday, December 04, 2009, 1100-1330 Location: Foster City Crowne PlazaEvent fee:$0 online before closing; $40 on site. Online registration and further details: http://www.caco-ca.orgRegistration deadline: 12/2/2009  (it will close sooner if the seating cap is reached)Additional Details: Visit the luncheons page Visit CACO website**********************************************************************************

UCSC Extension in Silicon Valley, Saturday Dec. 5, 2009

Course: Biotechnology Basics for Non-ScientistsDate and Time: Saturday, Dec. 5, 2009, 9:00 am – 4:00 pmLocation: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa ClaraTuition: $235; Early enrollment discount $211.50

Course DescriptionBiotechnology focused articles appear in the newspapers almost every day. For the layperson, it can be a challenge to understand and appreciate this technology and its potential implications for human health, public policy and the Bay Area economy. This seminar provides non-scientists with an accessible and stimulating introduction to the world of biotechnology. The course begins with an overview of the basic concepts in molecular biology and genetics that serve as a foundation for biotechnology. The instructor then highlights gene-based technology and important biotechnology breakthroughs, especially as they relate to Bay Area companies and institutions. He explores the impacts and the future of this cutting-edge discipline, and students leave the course with a new vocabulary and a solid understanding of the power and potential of biotechnology. No scientific background is assumed.

Instructor Background

Raxit J. Jariwalla, Ph.D., is senior researcher in nutrition and infectious diseases at the Dr. Rath Research Institute in Santa Clara, California. He was formerly head of the virology and immunodeficiency research program at the Linus Pauling Institute of Science and Medicine, and principal research investigator at the California Institute for Medical Research. Dr. Jariwalla is recognized for his contributions to virology, carcinogenesis, immunodeficiency disease and nutrition research.

***************************************************************************************

Bio2Device Group, Tuesday Evening, Dec. 8, 2009

Topic: “Science + Commercialization = Valuation. Building a Commercial Story that Resonates with Prospective Partners.”Speaker: Harris Kaplan, President and Chief Executive Officer, HealogixDate and Time: Tuesday, Dec.. 8, 2009, 6:00 – 9:00 pmLocation: Location: TIPS Group Law Offices , 1000 Elwell Court, Palo Alto, CA 94303Advanced registration is required see bio2devicegroup.org website for details a week prior to event.Cost: Fee for light dinner with range depending on timing of registration:

Topic Description

22 5/6/2023

The biotech IPO window has been closed for some time now and is unlikely to reopen anytime soon. As a result, biotech executives are increasingly reliant on a big pharma or big biotech to provide the capital needed to continue to develop promising new compounds and the competition for pharma or biotech dollars is intense. The larger companies differ significantly from financial investors. They are at least as concerned about how the product will perform in the market post launch as they are about the science. Thus, it is as important for a biotech executive understand the commercialization opportunity and to make that story come to life for an executive. Think venture capital but without a requirement that “monies have to be put to work.”  A biotech executive has to make one of these larger companies want to do a deal with your company.

This talk will focus on how biotech executives go about building a robust commercial story – what elements need to be included in that story and how to position compounds so they are very attractive to pharma and big biotech scientists and business development executives. Most biotech deals get one opportunity to present their technology and/or product. This talk will help company executives make that one time count.

Speaker BioHarris Kaplan is currently President and Chief Executive Officer of Healogix, a consultancy formed in late 2005 that advises companies on how to create and maximize the value of new products in development.Harris has extensive experience in the pharmaceutical industry both on the client and consulting side of the business and has worked on the introduction of more than 75 new products including Lipitor, Crestor, Nexium, Rituxan, and Herceptin.

Harris co-founded Migliara-Kaplan Associates which became the world’s largest custom marketing research company serving 19 of the top 20 pharmaceutical companies. Migliara-Kaplan Associates specialized in helping companies identify new product opportunities and then maximizing the commercial potential of new products in development. Migliara-Kaplan was acquired by NFO in 1996 and is now part of TNS Healthcare. Harris was also cofounder of Cozint Interactive which was acquired by GFK, the German based research company. Harris serves as an advisor to several venture capital funds and is on the Board of Directors of Informedix and the Kernan Orthopedic Hospital.

23 5/6/2023